Sotrovimab is much less effective against BA.2... - CLL Support
Sotrovimab is much less effective against BA.2 sub variant - possibly 27 times less effective.
You need to be a member of this community to see this post.
Read more about...
9 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
COVID-19 hospitalizations soaring in England.
assuming that COVID-19 is endemic and that Omicron is mild. But the confluence of BA.2 subvariant...
COVID and (lack of) access to monoclonal antibody treatments
I am trying to put a plan in place for if I get COVID. After speaking to my PCP and directors of...
Combining the Influenza and COVID-19 vaccines.
with a COVID-19 vaccine might make things easier.?
This approach is now being tested.
Pfizer...
Efficacy of the Molnupiravir antiviral pill - Help!
com/cllsupport/posts/146889712/new-oral-antiviral-treatments-for-covid-19-may-not-be-far-away-molnup
STORM CHASER MISSES THE TARGET
com/cllsupport/posts/146322652/new-drug-cuts-deaths-among-patients-with-no-covid-antibodies?response
Monoclonal antibody infusion
Travel Insurance questions on Acalabrutinib
REGENERON FREE CLINICS IN FLORIDA
COVID, Pneumonia and healthcare
Monoclonal antibodies for those who have no immunity after vaccine
